DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model.

NAR Cancer · 2022 · PMC9303272 · PMID 35875052

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The results showed a highly significant decrease in clonal contribution of the LRRC15- cells at both primary injection sites (Figure 2A ), as well as at their various metastatic sites (Figure 2B – E ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.